Roble, Belko & Company, Inc Regeneron Pharmaceuticals, Inc. Transaction History

Roble, Belko & Company, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $31,953 - $37,174	-91 Closed	0 $0
Q2 2018 Aug 08, 2018	SELL	$284.6 - $344.99 $18,499 - $22,424	-65 Reduced 41.67%	91 $31,000
Q1 2018 May 14, 2018	BUY	$315.82 - $393.78 $28,739 - $35,833	91 Added 140.0%	156 $54,000
Q4 2017 Jan 30, 2018	BUY	$358.63 - $469.95 $23,310 - $30,546	65	65 $24,000

1,497

82.8M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $72.4B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Roble, Belko & Company, Inc, based on Form 13F filings with the SEC.

Stay updated on Roble, Belko & Company, Inc with notifications on news.